Essais liés10clinical trials
VilleHartfordlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07164443

Ouvrir le site du centre

Essais cliniques associés

10
MoléculeIndication / populationPhaseNCTTitreStatut
Evolocumab Maladie coronarienne Phase 4 NCT05284747 EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction ACTIVE_NOT_RECRUITING
Percutaneous Mechanical Circulatory Support Maladie coronarienne Non applicable NCT06445608 PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm RECRUITING
Arctic Front™ Cardiac Cryoablation Catheter System Maladie coronarienne À vérifier NCT05005949 STOP Persistent AF PAS ACTIVE_NOT_RECRUITING
Bevacizumab Cancer Phase 3 NCT07198074 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer RECRUITING
Pelacarsen (TQJ230) Accident vasculaire cérébral Phase 3 NCT07517263 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) ACTIVE_NOT_RECRUITING
Pasritamig Cancer Phase 3 NCT07164443 KLK2-comPAS — A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) RECRUITING
Cenobamate Épilepsie Phase 4 NCT06453213 Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy ACTIVE_NOT_RECRUITING
Renal Denervation (Symplicity Spyral™) Hypertension Non applicable NCT05198674 SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN ACTIVE_NOT_RECRUITING
Middle Meningeal Artery embolization Migraine Non applicable NCT06735833 MMA Embolization for Refractory Chronic Migraine ACTIVE_NOT_RECRUITING
Bevacizumab Cancer Phase 2 NCT00861705 Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery COMPLETED